BIIB021 Free base 

To Order Contact us: stephen@expresspharmapulse.com

gel casting base for evs3100
EVS3100-BASE ea
EUR 301

gel casting base for evs3200
EVS3200-BASE ea
EUR 301

gel casting base for evs3300
EVS3300-BASE ea
EUR 301

Carubicin (Free base)
B1853-1
EUR 153

Carubicin (Free base)
B1853-5
EUR 457

FIPI (free base)
B2372-25
EUR 631

FIPI (free base)
B2372-5
EUR 196

Terbinafine (Free base)
B2423-250
EUR 207

Terbinafine (Free base)
B2423-50
EUR 120

MCC950 (Free base)
B1031-1
EUR 153

MCC950 (Free base)
B1031-5
EUR 457

Apatinib (Free base)
B1613-25
EUR 414

Apatinib (Free base)
B1613-5
EUR 142

AZD4547, Free Base
ADC-P-063 unit Ask for price

AZD8055, Free Base
ADC-P-064 unit Ask for price

Cyclopamine, Free Base
ADC-P-079 unit Ask for price

Ixabepilone, Free Base
ADC-P-104 unit Ask for price

R406(free base)
E1KS1533 2mg
EUR 521

RPR107393 free base
HY-100299 1mg
EUR 481

FR167344 free base
HY-100301 1mg
EUR 2637

FR183998 free base
HY-100302 1mg
EUR 1127

FR194738 free base
HY-100303 1mg
EUR 1990

Vatalanib (free base)
HY-10203 5mg
EUR 119

Masupirdine (free base)
HY-109118 1mg
EUR 223

R406 (free base)
HY-11108 10mM/1mL
EUR 231

ITI214 (free base)
HY-12501 100mg
EUR 2943

AS2863619 (free base)
HY-126675 5mg
EUR 1175

AZD3839 (free base)
HY-13438 50mg
EUR 1014

Ripasudil free base
HY-15685A 10mg
EUR 408

YM158 (free base)
HY-U00355 1mg
EUR 2309

THZ1 (Free base)
9664-25
EUR 1023

THZ1 (Free base)
9664-5
EUR 294

LY2835219 free base
A3575-100 100 mg
EUR 572
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

LY2835219 free base
A3575-25 25 mg
EUR 258
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

LY2835219 free base
A3575-5 5 mg
EUR 142
Description: LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity.

R406 (free base)
A5880-100 100 mg
EUR 1210
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)
A5880-25 25 mg
EUR 514
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)
A5880-5 5 mg
EUR 166
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)
A5880-5.1 10 mM (in 1mL DMSO)
EUR 264
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

R406 (free base)
A5880-S Evaluation Sample
EUR 81
Description: R406 is a potent SYK inhibitorSpleen tyrosine kinase (SYK) is a non-receptor tyrosine kinase mainly expressed in hematopoietic cells. It transmits signals from a variety of cell surface receptors including CD74, Fc receptor and integrins.

Rucaparib (free base)
A8893-10 10 mg
EUR 200
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)
A8893-200 200 mg
EUR 1036
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)
A8893-5 5 mg
EUR 137
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)
A8893-5.1 10 mM (in 1mL DMSO)
EUR 142
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Rucaparib (free base)
A8893-50 50 mg
EUR 456
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.

Lapatinib, Free base
2138-100
EUR 387

Lapatinib, Free base
2138-25
EUR 191

Ruxolitinib, Free base
2139-100 Ask for price

Ruxolitinib, Free base
2139-25
EUR 533

Ruxolitinib, Free base
2139-5
EUR 207

Imatinib, Free base
2141-100
EUR 147

Imatinib, Free base
2141-1000
EUR 419

Linsitinib, Free base
2294-25
EUR 566

Linsitinib, Free base
2294-5
EUR 185

Tipifarnib, Free base
2296-1
EUR 142

Tipifarnib, Free base
2296-5
EUR 414

Vatalanib, Free Base
2026-25
EUR 305

Vatalanib, Free Base
2026-5
EUR 126

Erlotinib, Free Base
2048-100
EUR 158

Erlotinib, Free Base
2048-1000
EUR 387

Sunitinib, Free base
2097-100
EUR 191

Sunitinib, Free base
2097-1000
EUR 501

Sunitinib, Free base
2097-25
EUR 115

Xylazine (free base)
Q-1445.0025 25.0g
EUR 321
Description: Sum Formula: C12H16N2S; CAS# [7361-61-7]

PLX5622 (free base)
B2965-25 25 mg
EUR 753

PLX5622 (free base)
B2965-5 5 mg
EUR 227

TMB free base
TB0954 1g
EUR 70.88
  • Product category: Biochemicals/Indicators/Stains/Immuno Related

BIIB021
HY-10212 50mg
EUR 340

BIIB021
A4058-10 10 mg
EUR 142
Description: BIIB021 is a selective inhibitor of Hsp90 with Ki and EC50 values of 1.7 nM and 38 nM, respectively.[1] HSP90 (heat shock protein 90) is widely expressed as a molecular chaperone.

BIIB021
A4058-100 100 mg
EUR 421
Description: BIIB021 is a selective inhibitor of Hsp90 with Ki and EC50 values of 1.7 nM and 38 nM, respectively.[1] HSP90 (heat shock protein 90) is widely expressed as a molecular chaperone.

BIIB021
A4058-5 5 mg
EUR 113
Description: BIIB021 is a selective inhibitor of Hsp90 with Ki and EC50 values of 1.7 nM and 38 nM, respectively.[1] HSP90 (heat shock protein 90) is widely expressed as a molecular chaperone.

BIIB021
A4058-5.1 10 mM (in 1mL DMSO)
EUR 121
Description: BIIB021 is a selective inhibitor of Hsp90 with Ki and EC50 values of 1.7 nM and 38 nM, respectively.[1] HSP90 (heat shock protein 90) is widely expressed as a molecular chaperone.

BIIB021
A4058-50 50 mg
EUR 293
Description: BIIB021 is a selective inhibitor of Hsp90 with Ki and EC50 values of 1.7 nM and 38 nM, respectively.[1] HSP90 (heat shock protein 90) is widely expressed as a molecular chaperone.

BMS-345541 (Free base)
B1907-1
EUR 142

BMS-345541 (Free base)
B1907-5
EUR 414

UNC-926, free base
B2158-25
EUR 631

UNC-926, free base
B2158-5
EUR 196

SB-334867 free base
B3423-100 100 mg
EUR 599
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

SB-334867 free base
B3423-25 25 mg
EUR 290
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

SB-334867 free base
B3423-5 5 mg
EUR 128
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

SB-334867 free base
B3423-5.1 10 mM (in 1mL DMSO)
EUR 131
Description: SB-334867 free base is a selective antagonist of orexin-1 receptor [1].Orexin-A and orexin-B are two peptides isolated from rat hypothalamus. They are involved in some physiological functions such as the control of feeding, energy metabolism and regulation of the sleep-wake cycle.

GSK J4 free base
B5959-10 10 mg
EUR 373
Description: GSK J4 free base

GSK J4 free base
B5959-50 50 mg
EUR 1198
Description: GSK J4 free base

BMS-345541(free base)
B4655-10 10 mg
EUR 235
Description: BMS-345541(free base) is a selective inhibitor of IKK-1 and IKK-2 with IC50 value of 4?M and 0.3?M, respectively [1].IKK is also known as nuclear factor kappa-B kinase subunit inhibitor and involves in cytokine-activated intracellular signaling pathways.

BMS-345541(free base)
B4655-5 5 mg
EUR 171
Description: BMS-345541(free base) is a selective inhibitor of IKK-1 and IKK-2 with IC50 value of 4?M and 0.3?M, respectively [1].IKK is also known as nuclear factor kappa-B kinase subunit inhibitor and involves in cytokine-activated intracellular signaling pathways.

BMS-345541(free base)
B4655-50 50 mg
EUR 595
Description: BMS-345541(free base) is a selective inhibitor of IKK-1 and IKK-2 with IC50 value of 4?M and 0.3?M, respectively [1].IKK is also known as nuclear factor kappa-B kinase subunit inhibitor and involves in cytokine-activated intracellular signaling pathways.

Staurosporine, >99% Free Base
BC090-001 1mg
EUR 246

Staurosporine, >99% Free Base
BC090-005 5mg
EUR 340

Vandetanib, >99% Free Base
BC098-025 25mg
EUR 232

Vandetanib, >99% Free Base
BC098-050 50mg
EUR 286

Vandetanib, >99% Free Base
BC098-100 100mg
EUR 313

Vandetanib, >100% Free Base
BC098-500 500mg
EUR 658

FK-448 Free base
HY-100193 10mg
EUR 1887

BIIB021 Free base